Q3 PREVIEW: St Jude set for another solid quarter
This article was originally published in Clinica
Executive Summary
St Jude Medical is expected to post another quarter of growth in Q3, with analysts predicting sales of $1.39bn, up 4% year-on-year. Furthermore, they anticipate adjusted earnings-per-share of $0.96, compared with $0.90 in the same period last year.